Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-centre Feasibility Study Investigating the Use of in Vivo Dosimetry in Patients Receiving High Dose Rate (HDR) Brachytherapy for Gynaecological and Prostate Cancers

NCT06863090 is registered in ClinicalTrials.gov with East and North Hertfordshire NHS Trust as lead sponsor.

NCT NCT06863090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06863090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-centre Feasibility Study Investigating the Use of in Vivo Dosimetry in Patients Receiving High Dose Rate (HDR) Brachytherapy for Gynaecological and Prostate Cancers
Lead sponsor
East and North Hertfordshire NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2025
Completion date
March 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynaecological cancer, prostate cancer